Phillip G. Febbo - 02 Jun 2025 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Role
Chief Scientific & Med Officer
Signature
/s/ Jonathan Wygant, as attorney-in-fact
Issuer symbol
VCYT
Transactions as of
02 Jun 2025
Net transactions value
-$79,017
Form type
4
Filing time
04 Jun 2025, 17:00:49 UTC
Previous filing
10 Mar 2025
Next filing
04 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Febbo Phillip G. Chief Scientific & Med Officer 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO /s/ Jonathan Wygant, as attorney-in-fact 04 Jun 2025 0001649245

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCYT Common Stock Tax liability $79,017 -2,955 -2.8% $26.74 103,745 02 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is reporting the withholding of 1,688 and 1,267 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 3,324 and 2,494 Restricted Stock Units, respectively, granted on October 2, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person.